Showing results (1-10 of 210) with videos related to
Sort By:
Pageof 21
The Journal of Pharmacology and Experimental Therapeutics|June 17, 1998
Novel single-point plasma or saliva dextromethorphan method for determining CYP2D6 activityO Y Hu, H S Tang, H Y Lane, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 1, 1995
Haloperidol plasma concentrations in Taiwanese psychiatric patientsH Y Lane, H N Lin, H G Hwu, et al.Psychopharmacology|August 13, 1999
In-vitro and in-vivo evaluation of the drug-drug interaction between fluvoxamine and clozapineW H Chang, B Augustin, H Y Lane, et al.Psychiatry Research|March 24, 1997
Dextromethorphan phenotyping and haloperidol disposition in schizophrenic patientsH Y Lane, O Y Hu, M W Jann, et al.International Journal of Clinical Pharmacology and Therapeutics|November 10, 2000
Disposition of olanzapine in Chinese schizophrenic patientsH Y Lane, H C Liu, C M VanDenBerg, et al.The Journal of Clinical Psychiatry|September 12, 2000
Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patientsM L Lu, H Y Lane, K P Chen, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 1, 1997
Clozapine dosages and plasma drug concentrationsW H Chang, S K Lin, H Y Lane, et al.The Journal of Clinical Psychiatry|May 19, 2000
Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levelsH Y Lane, W C Chiu, J C Chou, et al.The Journal of Clinical Psychiatry|March 13, 1999
Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statisticsH Y Lane, Y C Chang, W H Chang, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 1, 1997
Blood levels of reduced haloperidol versus clinical efficacy and extrapyramidal side effects of haloperidolH Y Lane, H N Lin, O Y Hu, et al.Pageof 21